Prosecution Insights
Prosecution Insights
6 pending office actions • 5 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (50%) |
| No statute on record | 3 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ALDARONDO, DASIA ALI | 1 | 0.0% | +0.0% |
| LEONARD, ARTHUR S | 1 | 50.5% | +50.7% |
| WHITE, DAWANNA SHAR-DAY | 1 | 62.3% | +24.5% |
| VIJAYARAGHAVAN, JAGAMYA NMN | 1 | 67.7% | +39.0% |
| SULLIVAN, STEPHANIE LAUREN | 1 | 60.9% | +38.7% |
| SHIN, DANA H | 1 | 27.2% | +27.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16781732 | COMBINATION GENE TARGETS FOR IMPROVED IMMUNOTHERAPY | SHIN, DANA H | 28d overdue |
| 18547627 | METHODS FOR EXPANDING REGULATORY T CELLS | ALDARONDO, DASIA ALI | 21d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17779458 | METHODS FOR ACTIVATION AND EXPANSION OF TUMOR INFILTRATING LYMPHOCYTES | VIJAYARAGHAVAN, JAGAMYA NMN | 66d overdue |
| 17426059 | GENE-REGULATING COMPOSITIONS AND METHODS FOR IMPROVED IMMUNOTHERAPY | SULLIVAN, STEPHANIE LAUREN | 31d overdue |
| 16781732 | COMBINATION GENE TARGETS FOR IMPROVED IMMUNOTHERAPY | SHIN, DANA H | 28d overdue |
| 18000500 | NITROGEN-CONTAINING FUSED BICYCLIC COMPOUNDS AND THEIR USE AS UBIQUITIN-SPECIFIC-PROCESSING PROTEASE 1 (USP1) INHIBITORS | WHITE, DAWANNA SHAR-DAY | 20d |
| 18065464 | GENE-REGULATING COMPOSITIONS AND METHODS FOR IMPROVED IMMUNOTHERAPY | LEONARD, ARTHUR S | 27d |
| Art Unit | Apps |
|---|---|
| 1635 | 2 |
| 1647 | 1 |
| 1631 | 1 |
| 1627 | 1 |
| 1633 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18547627 | METHODS FOR EXPANDING REGULATORY T CELLS | ALDARONDO, DASIA ALI | 1647 | §103 | Non-Final OA | 21d | Pending | Aug 23, 2023 |
| 18065464 | GENE-REGULATING COMPOSITIONS AND METHODS FOR IMPROVED IMMUNOTHERAPY | LEONARD, ARTHUR S | 1631 | Other | Non-Final OA | 27d | Pending | Dec 13, 2022 |
| 18000500 | NITROGEN-CONTAINING FUSED BICYCLIC COMPOUNDS AND THEIR USE AS UBIQUITIN-SPECIFIC-PROCESSING PROTEASE 1 (USP1) INHIBITORS | WHITE, DAWANNA SHAR-DAY | 1627 | §103 | Non-Final OA | 20d | Pending | Dec 01, 2022 |
| 17779458 | METHODS FOR ACTIVATION AND EXPANSION OF TUMOR INFILTRATING LYMPHOCYTES | VIJAYARAGHAVAN, JAGAMYA NMN | 1633 | Other | Non-Final OA | 66d overdue | Pending | Nov 22, 2022 |
| 17426059 | GENE-REGULATING COMPOSITIONS AND METHODS FOR IMPROVED IMMUNOTHERAPY | SULLIVAN, STEPHANIE LAUREN | 1635 | §103 | Non-Final OA | 31d overdue | Pending | Jul 27, 2021 |
| 16781732 | COMBINATION GENE TARGETS FOR IMPROVED IMMUNOTHERAPY | SHIN, DANA H | 1635 | Other | Non-Final OA | 28d overdue | Pending | Feb 04, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial